Hodgkin lymphoma incidence statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of Hodgkin lymphoma, 2015-2017, UK.

 

Proportion of all cases

Percentage Hodgkin lymphoma is of total cancer cases, 2015-2017, UK

 

Age

Peak rate of Hodgkin lymphoma cases, 2015-2017, UK

Trend over time

Change in hodgkin lymphoma incidence rates since the early 1990s, UK

 

Hodgkin lymphoma is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2017).[1-4]

In females in the UK, Hodgkin lymphoma is not among the 20 most common cancers (less than 1% of all new female cancer cases). In males in the UK, it is the 19th most common cancer (less than 1% of all new male cancer cases).

41% of Hodgkin lymphoma cases in the UK are in females, and 59% are in males.

Hodgkin lymphoma incidence rates (European age-standardised (AS) rates Open a glossary item) for persons are similar to the UK average in all the UK constituent countries.

Hodgkin Lymphoma (C81), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2017

  England Scotland Wales Northern Ireland UK
Female Cases 741 86 38 18 883
Crude Rate 2.6 3.1 2.4 1.9 2.6
AS Rate 2.7 3.0 2.4 1.9 2.7
AS Rate - 95% LCL 2.5 2.4 1.6 1.0 2.5
AS Rate - 95% UCL 2.8 3.7 3.1 2.7 2.8
Male Cases 1,061 117 46 38 1,262
Crude Rate 3.9 4.4 3.0 4.1 3.9
AS Rate 4.0 4.5 3.1 4.4 4.0
AS Rate - 95% LCL 3.7 3.7 2.2 3.0 3.8
AS Rate - 95% UCL 4.2 5.3 4.0 5.8 4.2
Persons Cases 1,802 203 84 56 2,145
Crude Rate 3.2 3.7 2.7 3.0 3.2
AS Rate 3.3 3.7 2.7 3.1 3.3
AS Rate - 95% LCL 3.1 3.2 2.1 2.3 3.2
AS Rate - 95% UCL 3.5 4.2 3.3 3.9 3.4

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2017, ICD-10 C81.

Last reviewed:

Hodgkin lymphoma incidence shows a clear bimodal age distribution, with the first peak in incidence rates in young adults, and the second peak in older females and males. In the UK in 2015-2017, on average each year almost 3 in 20 new cases (13%) were in people aged 75 and over.[1-4] This is a lower proportion of cases in older age groups compared with most cancers.

Age-specific incidence rates rise sharply during childhood and peak first in young adults aged 20-24. Rates then decrease until middle age before rising again to reach a second peak.The highest rates are in in the 20 to 24 age group for females and the 75 to 79 age group for males.

Incidence rates are significantly lower in females than males in a number of (mainly older) age groups.The gap is widest at age 05 to 09, when the age-specific incidence rate is 2.5 times lower in females than males.

Hodgkin lymphoma (C81), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, UK, 2015-2017

For Hodgkin lymphoma, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015-2017, C81.

Last reviewed:

Hodgkin lymphoma European age-standardised (AS) incidence rates Open a glossary item for females and males combined increased by 36% in the UK between 1993-1995 and 2015-2017.[1-4] The increase was of a similar size in females and males.

For females, Hodgkin lymphoma AS incidence rates in the UK increased by 39% between 1993-1995 and 2015-2017. For males, Hodgkin lymphoma AS incidence rates in the UK increased by 34% between 1993-1995 and 2015-2017.

Over the last decade in the UK (between 2005-2007 and 2015-2017), Hodgkin lymphoma AS incidence rates for females and males combined increased by 19%. In females AS incidence rates increased by 19%, and in males rates increased by 19%.

Hodgkin Lymphoma (ICD-10 C81), European Age-Standardised Incidence Rates, UK, 1993-2017

Hodgkin lymphoma incidence rates have increased overall in most broad age groups in females and males combined in the UK since the early 1990s, but have remained stable in some.[1-4] Rates in 0-24s have increased by 25%, in 25-49s have increased by 23%, in 50-59s have remained stable, in 60-69s have increased by 38%, in 70-79s have increased by 115%, and in 80+s have increased by 109%.

Hodgkin Lymphoma (ICD-10 C81), European Age-Standardised Incidence Rates, By Age, UK, 1993-2017

For Hodgkin lymphoma, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2017, ICD-10 C81.

Last reviewed:

Staging for Hodgkin lymphoma most commonly uses the Ann Arbor system.[1]

Data by stage are not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past. However this is improving and plans for a nationally consistent dataset in England are underway.[2] In the meantime, incidence by stage is available for the former Anglia Cancer Network in the east of England for the period 2004-2008.[3] Anglia covers around 5% of the population of England and may not be representative of the country as a whole due to differences in underlying demographic factors (such as age, deprivation or ethnicity), as well as variation in local healthcare provision standards and policies.

Over half (55%) of men and women diagnosed with Hodgkin lymphoma present at stage I or II.[3] For around a sixth (17%) of patients, the stage is not known.

Hodgkin Lymphoma (C81), Proportion of Cases Diagnosed at Each Stage, Adults (Aged 15-99), Former Anglia Cancer Network, 2004-2008

Stage at Diagnosis Proportion of cases
Stage I 24.4%
Stage II 30.8%
Stage III 15.4%
Stage IV 12.8%
Stage not known 16.7%

Percentages may not sum to 100 due to rounding

References

  1. Smithers DW. Summary of papers delivered at the Conference on Staging in Hodgkin's Disease (Ann Arbor). Cancer Res 1971; 31(11):1869-70.
  2. Department of Health. Improving outcomes: a strategy for cancer. London: Department of Health; 2011.
  3. Data were provided by The National Cancer Registration Service, Eastern Office on request.

About this data

Data is for: Former Anglia Cancer Network, 2004-2008, ICD-10 C81

Last reviewed:

Hodgkin lymphoma incidence rates are projected to rise by 5% in the UK between 2014 and 2035, to 4 cases per 100,000 people by 2035.[1] This includes an increase for males and a drop for females.

For males, Hodgkin lymphoma European age standardised (AS) Open a glossary item incidence rates in the UK are projected to rise by 9% between 2014 and 2035, to 5 cases per 100,000 by 2035.[1] For females, rates are projected to fall by 1% between 2014 and 2035, to 3 cases per 100,000 by 2035.[1]

Hodgkin lymphoma (C81), Observed and Projected Age-Standardised Incidence Rates, by Sex, UK, 1979-2035

 

It is projected that 2,473 cases of Hodgkin lymphoma (1,480 in males, 993 in females) will be diagnosed in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C81

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

Hodgkin lymphoma incidence rates (European age-standardised (AS) rates Open a glossary item) in England in females are similar in the most deprived quintile compared with the least, and in males are 19% higher in the most deprived quintile compared with the least (2013-2017).[1]

It is estimated that there are around 85 more cases of Hodgkin lymphoma each year in males in England than there would be if every deprivation quintile had the same age-specific crude incidence rates as the least deprived quintile.

Hodgkin Lymphoma (C81), Estimated Average Number of Excess Cases per Year and European Age-Standardised Incidence Rates per 100,000 Population, by Deprivation Quintile, England, 2013-2017

No data are shown for females as the difference in age-standardised incidence rates between most and least deprived quintiles is not significant for females.

References

  1. Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011 . Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.

About this data

Data is for England, 2013-2017, ICD-10 C21.

Last reviewed:

Age-standardised Open a glossary item rates for White males with Hodgkin lymphoma range from 2.7 to 3.0 per 100,000. Rates for Asian males are similar, ranging from 2.7 to 4.7 per 100,000 and the rates for Black males are also similar, ranging from 1.8 to 3.8 per 100,000. For females there is a similar pattern - the age-standardised rates for White females range from 1.9 to 2.2 per 100,000, and rates for Asian and Black females are also similar ranging from 1.6 to 2.9 per 100,000 and 1.3 to 2.7 per 100,000 respectively.[1] There appears to be no significant variation in Hodgkin lymphoma incidence by ethnicity in the UK.

Ranges are given because of the analysis methodology used to account for missing and unknown data. For Hodgkin lymphoma, 6,399 cases were identified; 17% had no known ethnicity.

Last reviewed:

An estimated 21,600 people who had been diagnosed with Hodgkin lymphoma between 1991 and 2010 were alive in the UK at the end of 2010.[1]

References

  1. Macmillan Cancer Support and National Cancer Registration and Analysis Service. Cancer Prevalence UK Data Tables. London: NCRAS; 2015.

About this data

Data is for: Great Britain (1991-2010) and Northern Ireland (1993-2010), ICD-10 C81

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.